TSR Desk · biotech · 3 November 2026, 01:00 UTC
GraphTFactor: A graph-based approach for proteins transcription factor prediction
- What
- GraphTFactor: A graph-based approach for proteins transcription factor prediction
- Who
- arxiv.org
- When
- 2 November 2026, 05:00 UTC
- Category
- Biotech
- Primary source
- https://arxiv.org/abs/2610.40867
- What is not known
- This brief does not claim independent replication. Claims that appear only on X and not in the primary source stay unknown.
Experimental results show that GraphTFactor outperforms state-of-the-art methods on benchmark datasets, demonstrating the effectiveness of graph-based representations for TF prediction while providing interpretable insights into the sequence regions contributing to the model's predictions. It comes from a paper posted to arXiv on 2 November 2026. Transcription factors (TFs) play an important role in regulating gene expression, making their identification a fundamental task in computational biology. In this work, we propose GraphTFactor, a novel end-to-end framework that models protein sequences as graphs and directly classifies transcription factors. By encoding sequences into graph structures, the proposed approach naturally handles variable-length inputs while preserving relevant relational information, without imposing length constraints. To support reproducibility and practical adoption, we release an open-source software package and an interactive web application that let users easily perform TF prediction on custom sequences.
Why it counts
Experimental results show that GraphTFactor outperforms state-of-the-art methods on benchmark datasets, demonstrating the effectiveness of graph-based representations for TF prediction while providing interpretable insights into the sequence regions contributing to the model's predictions.
Sources
Primary source: primary source
What is not known
This brief does not claim independent replication. Claims that appear only on X and not in the primary source stay unknown.
No clip. The article still stands.